Archival of Human Biological Samples in CU-Med Biobank

NCT04706481 | Recruiting

• 1 other identifier: CREC 2019.152
• Study Type: observational
• Target: 10,000
• Locations: 1 country
• Sites: 1

Brief Summary

CU-Med Biobank collaborates with different researchers for collecting and distributing human biospecimens and clinical data for assisting scientific research.

Conditions

Healthy; Cancer; Heart Diseases; Neurological Diseases or Conditions; Kidney Diseases; Diabetes; Other Disease

Keywords

Biobanking

Outcome Measures

Primary Outcomes (2)

• To distribute human biospecimens for clinical research

  By using the biological samples from CU-Med Biobank, translational studies can be done.

  99 years

• To discover the pathological mechanism of different acute and chronic diseases such as cancer, stroke, heart disease, dementia & diabetes

  The relationship between different genome/proteome/bacteriome/virome and various diseases can be revealed, thus leading to a better prognostic and diagnostic outcome.

  99 years

Study Arms (2)

Healthy Control

Healthy subjects who have provided consent for specimen collection

Procedure: Specimen Collection

Cancer or Other Diseases

Diseased subjects who have provided consent for specimen collection

Procedure: Specimen Collection

Interventions

Specimen Collection PROCEDURE

Specimens obtained from surgical, phlebotomy or other non-invasive procedure

Cancer or Other Diseases; Healthy Control

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The diverse group of biorepositories with focus on normal cohorts and cancer-related or other disease cohorts.

You may qualify if:

• Enrolled subjects that have provided signed consent for the specimens and de-identified data to be collected, stored and distributed.

You may not qualify if:

• Subjects without signed informed consent for the specimens and de-identified data to be collected, stored and distributed.

Sponsors & Collaborators

• Chinese University of Hong Kong: lead

Study Sites (1)

CU-Med Biobank

Hong Kong, Hong Kong

RECRUITING

Related Links

• Webpage of CU-Med Biobank

Biospecimen

Retention: SAMPLES WITH DNA

Buffy coats, plasma, serum, tissues, pleural effusion, urine and stool, etc

MeSH Terms

Conditions

Neoplasms; Heart Diseases; Kidney Diseases; Diabetes Mellitus; Disease

Interventions

Specimen Handling

Condition Hierarchy (Ancestors)

Cardiovascular Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Investigative Techniques

Study Officials

• Ching Wan MA, MB BChir

  Chinese University of Hong Kong

  STUDY CHAIR

Central Study Contacts

Terry OR, Ph.D

CONTACT

852-26285221; terryor@cuhk.edu.hk

Marcus LAW, M. Phil

CONTACT

852-26285221; marcuslaw@cuhk.edu.hk

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 99 Years
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: December 28, 2020
• First Posted: January 12, 2021
• Study Start: January 1, 2020
• Primary Completion (Estimated): December 1, 2050
• Study Completion (Estimated): December 1, 2050
• Last Updated: March 12, 2026

Record last verified: 2026-03

Locations

HK (1)